Six Areas to Assess When Qualifying a Clinical Trial Vendor

The right Vendor qualification process protects a study from startup through inspection. 

Below are six critical areas to cover when qualifying a clinical trial Vendor, with a sample RFI question for each. Each question reflects current, applicable regulations and guidance. 

The remaining 14 questions are available in our full guide, free to download at the end of this post. 

1. Training

Verify that individuals assigned to a trial are qualified and trained for their specific roles, including retraining as necessary. 

Does the business operate a risk-based, role-specific training program covering ICH E6(R3) GCP, data integrity, therapeutic area requirements and applicable SOPs, with documented completion records, competency assessments, training gap analyses, and retraining triggered by protocol amendments or regulatory updates? 

2. Quality Management System

Ensure that a robust, risk-based Quality Management System (QMS) is in place, aligned with applicable ICH principles. 

Does the business maintain a documented, risk-based Quality Management System (QMS) covering corrective and preventive action (CAPA) processes, internal/external audit programs, quality metrics dashboards, management review, and continuous improvement — aligned to ISO 9001:2015, ICH Q10 principles and applicable GxP regulations?

3. Risk Management

Assess whether risk management practices are aligned to relevant regulations, covering risk identification, signal monitoring, and periodic review.

Does the business apply ICH E6(R3) Annex 1 / ICH Q9-aligned risk management processes including proactive risk identification, protocol-specific Risk Management Plans, risk signal monitoring, and documented periodic review triggered by protocol amendments, new safety data, or serious breaches? 

4. Vendor Oversight

Ascertain whether proportionate, risk-based Vendor oversight is in place, covering approved Vendor lists, qualification, requalification, documented audit rights, and sub-Vendor oversight, in alignment with ICH E6(R3) requirements. 

Does the business maintain a risk-stratified, qualified vendor program that includes initial qualification assessments, performance-based re-qualification, audit rights, KPI tracking, and subcontractor oversight — with a maintained list of approved providers and qualification/requalification history? 

5. Computer System Validation

Confirm that all GxP-relevant computerized systems are validated throughout their lifecycle, with formal change control, maintained audit trails, and regular backups in place. 

Does the business validate all GxP-relevant computerized systems in accordance with GAMP5 (2nd ed.) and 21 CFR Part 11 / EU Annex 11, maintain a validated state throughout the system lifecycle, document change control and periodic reviews, and ensure audit trail integrity and backup/recovery procedures?

6. Data Integrity

Determine that ALCOA+ principles are applied across all GxP records. Vendors are expected to demonstrate compliance, maintain audit trails of all changes, and periodically assess adherence to these requirements. 

Does the business define and enforce ALCOA+ data integrity principles (Attributable, Legible, Contemporaneous, Original, Accurate, Complete, Consistent, Enduring, Available) in all GxP systems and processes, maintain complete audit trails, conduct regular data integrity audits, and have CAPAs for identified breaches? 

The remaining 14 questions

The full guide shares 20 topics that are essential to cover when qualifying a clinical trial vendor, complete with sample questions and regulatory references. Download it for free today.

Sponsors on Diligent360 get access to current and comprehensive qualification information across GxP Vendor categories — with side-by-side Vendor comparisons built into the platform. Our SMEs conduct comprehensive risk scoring tailored to your trial criteria and study needs, so you can identify the right Vendors and make decisions with confidence.